Healthcare analytics company Panalgo released its 2021 State of Healthcare Analytics Benchmarking Report, featuring insight into the use of RWD (real world data). The report was based on an in-depth survey on how life sciences companies utilize RWD by Fierce Pharma. The authors also discuss barriers […]
Icon Acquires PRA Health Sciences for $12 Billion
The use of decentralized trials has surged during COVID-19. CRO (contract research organization) Icon is set to acquire PRA Health Sciences. This will bring big changes to CROs and Icon is expected to direct anincreasing number of decentralized trials. “Icon, the Dublin-based CRO, will acquire […]
Reference Pricing Could Negatively Affect Vulnerable Populations
Some countries use QALYs (Quality-Adjusted Life Years) to assess whether or not to use a treatment or prescription drug. The authors note this approach would bring negative consequences for people with chronic illness, people with disabilities, and older individuals in the United […]
Webinar on Providing Meaningful Price Transparency Information
In order to comply with recent rulings, many organizations are sharing large amounts of data. However, not all data is necessary or even desired. Join this webinar to hear more about what consumers want to know—and what they don’t. Alison Greco of HealthSparq will share her insights. The webinar […]
Using RWE to Make Cost Decisions: A New Report
A recent article, published in JMCP (the Journal of Managed Care and Specialty Pharmacy), considers how RWE (real world evidence) can be utilized when making economic decisions. ICER (the Institute for Clinical and Economic Review) has incorporated RWE in making its recommendations, but few other […]
Payer Engagement Summit Videos on RWD Now Available
ISPOR held its first Payer Engagement Summit in 2020 to discuss the issues facing payers worldwide. The Summit featured discussions regarding the use of RWD (real world data). Payers face unique challenges when considering the use of RWD. Invited speakers included Fran Cunningham of the US […]
COVID-19 CARE Registry Provides Informative Data
Dr. Nancy Dreyer is the Chief Scientific Officer of IQVIA Real World Solutions. In a recent interview led by Dr. Patti Peeples, CEO of HealthEconomics.Com and Vice President of Evidence and Content at Scientist.com, the scientists discussed how IQVIA has taken on COVID-19. The CARE (COVID Active […]
Syapse Invests $68 Million in Expanding RWE to Improve Outcomes for Cancer Patients
Leading RWE (real world evidence) company Syapse has invested $68 million in a venture with Ally Bridge Group and Northpond Ventures. Syapse will expand its Learning Health Network. The overall goal is to improve outcomes for oncology patients. Additional goals are to reduce costs and to enhance […]
Telehealth Brings Change to Traditional Clinical Visit—and Billing
The start of the COVID-19 pandemic brought many changes to the conventional doctor’s visit. A report by McKinsey found that telehealth adoption rose from 11% to now 46%. Healthcare providers are seeing between 50 and 175 times the patients via telehealth. Continuous remote patient monitoring makes […]
What Does the FDA Think About RWE?
A year into the COVID-19 pandemic, the use of RWE in clinical study design is becoming more widespread. In a recent informative dialogue, Dr. Nancy Dreyer of IQVIA spoke with Dr. Amy Abernethy of the FDA regarding the different types of data included under the RWE umbrella. Dr. Abernethy provides […]
As Pandemic Slows, Will Pfizer Increase Vaccine Price?
Pfizer is charging the United States $19.50 per dose of its new vaccine to prevent COVID-19. Pfizer CFO Frank D’Amelio considers this “pandemic pricing.” He notes that a typical price for a vaccine produced by Pfizer is around $150 to $175. He expects the price for Pfizer’s COVID-19 vaccine to rise […]
Upcoming Webinar on COVID-19 Therapeutics and Vaccines
An upcoming webinar will review the data behind treatments for COVID-19, as well as vaccines that have received FDA emergency use approval. There are currently several treatments that are being evaluated by the FDA. This will be an informative event for many audiences, especially pharmacists in […]
Good News: RWE Shows Effectiveness of COVID-19 Vaccines
A recent study examines how the vaccines produced by Moderna and Pfizer might protect against COVID-19. RWE (real world evidence) shows that these vaccines are broadly effective—both in preventing infection and reducing incidence of serious disease. The Pfizer vaccine is 95% effective and the […]
Importing Prescription Drugs: What Does Biden Think?
According to former President Trump and current President Biden, Americans should be able to buy prescription drugs from other countries. Despite Biden’s assurances, skepticism remains high. Florida attempted to implement a prescription drug importation program, but faced serious issues. A $30 […]
A Conversation With Ge Bai Regarding Amazon’s Pharmacy Foray
In a recent podcast with Dr. Ge Bai of Johns Hopkins, important points are discussed relating to Amazon’s venture into the pharmacy space. Her extensive background in in public health and business make for an informative discussion. She discusses PBMs (pharmacy benefit managers) and the reasons […]
Do Hospitals Actually Mark Up Medications 250%?
A recent report examines the cost differences regarding medications in hospitals. A comparison across two dozen drugs led to the finding that the markup is an average of 250%. Over 30% of the hospitals included in the analysis did not stock biosimilars for the drugs analyzed. Although insurance […]
HealthEconomics.Com’s Value and Evidence Marketplace Seeking Organizations With EHR Data
The Value and Evidence Marketplace is an online tool that matches biomedical and biopharmaceutical researchers with suppliers for research. 24 of the top 30 pharmaceutical companies, along with over 75 biotech companies, utilize our Marketplaces in their studies. Clients are increasingly interested […]
Report on Impact of COVID-19 on Global Bioinformatics Market
A recent report discusses how COVID-19 affected the Bioinformatics Market. The impacts on five currencies (USD, EUR, AUD, GBP, JPY) are discussed. Chemoinformatics, genomics, proteomics, metabolomics, and transcriptomics were discussed, among other categories. The report addressed market […]
Prediction Models for COVID-19 Can’t Account for All Human Elements
Early in the COVID-19 pandemic, researchers were scrambling to predict how the disease would spread. One such model was developed at the University of Illinois, Urbana-Champaign, by two physicists: Nigel Goldenfeld and Sergei Maslov. They were able to adapt some of the tools used in their physics […]
Amalgam Rx, Inc. Acquires Avhana Health
Amalgam Rx. Inc. has acquired Avhana Health, a clinical decision support company with experience in electronic health records. This move will allow Amalgam Rx to build on Avhana’s existing tools and to expand into additional therapeutic areas. The result will be a simplified workflow for […]
Meta-Analysis Study on Kidney Cancer Utilizes Novel Techniques to Identify Biomarkers
The survival rates of patients with kidney cancer largely depend on identifying biomarkers. The identification of these biomarkers can help determine a course of treatment. A recent study, published in JAMA, compares data from 6 clinical trials and reported in 9 publications. The report examined how […]
Caesarean Section Procedure Can Vary in Price From 6k to 60k—At the Same Hospital
Women who undergo a caesarean section at the Van Ness site of the Pacific Medical Center in California might be surprised to find that the cost of their procedure may be vastly different from that of another woman in the same hospital. Costs range from $6,241 to $60,584 for this particular […]
Webinar: Reflections on Healthcare in 2020 and Visions for 2021
In a recent webinar, the authors discuss important changes and developments in 2020 regarding healthcare regulations. The fast pace of change is expected to continue through 2021. The No Surprises Act passed in December 2020, meant to address unexpected medical bills, will bring changes to a diverse […]
Webinar on RWE and Progress During COVID-19 Pandemic
The COVID-19 Pandemic has driven many researchers to incorporate RWE (real world evidence) into clinical trials. However, it can often be challenging to accomplish this task. In this webinar, Sandy Leonard and Akiko Shimamura of HealthVerity discuss advances regarding RWE in clinical trials. “The […]
Using Bayesian Methods in Control Arms of Clinical Trials
The use of single arm trials has become more widespread, especially as the COVID-19 has forced clinical trials to change or end early. An alternative approach is the use of synthetic control arms (SCAs), arms that can be created using Bayesian Dynamic Borrowing. In this method, data from patients […]
New Report Details How SDOH Impact Access to Prescription Drugs
In a recent report, CoverMyMeds discusses how SDOH (social determinants of health) are associated with many patients being forced to make difficult choices when it comes to their health. The COVID-19 pandemic has made these choices even more challenging as more Americans become uninsured or […]
6 Recommendations Regarding HTAs in the United States
A whitepaper was recently released by researchers at the USC Schaeffer Center and the Aspen Institute. The authors discuss half a dozen recommendations relating to HTAs (Health Technology Assessments) in the United States, which could lead to changes in the pricing of prescription drugs. […]
A Conversation with Peter Pitts on Drug Pricing and Medicare
In a recent podcast by Patients Rising Podcast, the hosts spoke with Peter Pitts. He co-founded and is currently president of the Center for Medicine in the Public Interest. He’s also served as Associate Commissioner for External Relations for the FDA, written a book on successful leadership, and […]
Outcry Over Nick Jonas in Super Bowl Commercial for Dexcom
Type 1 Diabetics typically check their blood glucose levels by pricking their finger with a needle to obtain a small blood sample. Insulin injections regulate this blood glucose level, but can cause significant financial hardship. In a Super Bowl commercial for Dexcom, Nick Jonas promoted an […]
Will a Committee Lead to Reduced Drug Prices in the United States?
Will a Committee Lead to Reduced Drug Prices in the United States The idea of an independent review board to regulate drug prices is gaining ground. Although pharmaceutical companies protest such a committee, pointing at lost innovation, many in the US support a Health Technology Assessment (HTA) […]
